GSK Sets Up $500 Million Venture Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
SR One will become part of new effort that reports to CEO.
You may also be interested in...
Russell Greig Leaves GSK's SR One
The managing partner and president of GSK's corporate venture group appears to have quietly moved on.
Russell Greig Leaves GSK's SR One
The managing partner and president of GSK's corporate venture group appears to have quietly moved on.
Pipeline Dreams: GSK’s Witty Outlines Plans To Lower Phase III Attrition
As Andrew Witty takes the helm at GlaxoSmithKline, he has set his sights on tackling one of the industry's biggest challenges: reducing attrition in the late-stage pipeline